Role of genetic screening in identifying susceptibility to acute fatty liver of pregnancy.
Ibdah
Jamal A
JA
Medical Pharmacology & Physiology, University of Missouri-Columbia, 65212, USA. ibdahj@health.missouri.edu
D015094:3-Hydroxyacyl CoA Dehydrogenases / Q000172:deficiency / Q000235:genetics; D000208:Acute Disease; D005234:Fatty Liver / Q000235:genetics*; D005260:Female; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing; D006801:Humans; D007231:Infant, Newborn; D063991:Mitochondrial Trifunctional Protein; D009097:Multienzyme Complexes / Q000235:genetics*; D015997:Neonatal Screening; D011247:Pregnancy; D011248:Pregnancy Complications / Q000235:genetics*
D009097:Multienzyme Complexes; D015094:3-Hydroxyacyl CoA Dehydrogenases; D063991:Mitochondrial Trifunctional Protein